The incidence of thyroid cancer has been increasing. After total thyroidectomy of well-
differentiated thyroid tumors with intermediate-or high-risk features on pathology …

Differentiated thyroid cancer (DTC) generally has a favorable prognosis; however, the
chance of a recurrence in patients with DTC is 20%, and 8% of patients with recurrence will …

The standard treatment of differentiated thyroid cancer (DTC) consists of surgery followed by
iodine-131 (131 I) administration. Although the majority of DTC has a very good prognosis …

Positron emission tomography–computed tomography (PET/CT) combines both functional
and anatomic information and provides in vivo molecular information on biological …

The recent availability of 124 I, due in part to the spread of PET scanners, has opened up
new possibilities for performing pre-therapeutic dosimetric studies in patients with …

Selected patients with thyroid cancer can benefit from the use of PET imaging with FDG or
with I-124. The PET scan impacts on management by providing (1) more accurate …

Although thyroid cancer is a comparatively rare malignancy, it represents the vast majority of
endocrine cancers and its incidence is increasing. Most differentiated thyroid cancers have …

Background After initial treatment of differentiated thyroid carcinoma (DTC) patients are
followed with thyroglobulin (Tg) measurements to detect recurrences. In case of elevated …

Simple Summary Since the 1940s, radioactive iodine has been used for functional imaging
and for treating patients with differentiated thyroid cancer (DTC). During this long-lasting …

Radioiodine scintigraphy and therapy has played a major role in the treatment and follow-up
of thyroid cancer patients for decades. Single-photon emission computed …